Las Vegas, NV -- (SBWIRE) -- 10/24/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: Sigma Labs Inc (OTCMKTS: SGLB), International Stem Cell Corp (OTCMKTS: ISCO), Transgenomic Inc (OTCMKTS: TBIO), Universal Bioenergy Inc (OTCMKTS: UBRG)
Sigma Labs Inc (OTCMKTS: SGLB) managed to keep its fall at -9.33% on above-normal volume of 7.73M shares. The stock settled at $0.136 after floating in a range of $0.13 to $0.15. Its latest price has reached market capitalization of $75.48 million. Its 52-week range has been $0.13 to $0.15. Sigma Labs, Inc. has two wholly-owned subsidiaries, B6 Sigma, Inc. and Sumner & Lawrence Limited (dba Sumner Associates). B6 Sigma, Inc. (B6 Sigma) develops precision manufacturing solutions and advanced materials technologies, as well as Reasearch and Development solutions for first-tier integrators and other commercial firms worldwide. Sumner Associates provide consultants to Federal government and commercial clients seeking productive solutions for development technologies.
Has SGLB Found The Bottom and Ready To Move Up? Find Out Here
International Stem Cell Corp (OTCMKTS: ISCO) traded down on a volume of 1.23 million, higher than its standard daily volume. Shares have dropped-7.60 % to $0.158. Over the last twelve months, the stock has lost-39.23% and faced a worst price of $0.13. International Stem Cell Corporation is a developmental-stage biotechnology company. The Company focused on therapeutic, biomedical and cosmeceutical product.
Has ISCO Found The Bottom And Ready To Gain Momentum? Find Out Here
Transgenomic Inc (OTCMKTS: TBIO) settled 3.39% higher at $0.610 on above-normal volume of 649,498.00 shares during the last trading day. The stock has its 12-month high at $0.93 and 52-week low price was $0.30. It traded in a range of $0.58 to $0.62 during the last trading day. Transgenomic, Inc. is a biotechnology company operates in two segments: Clinical Laboratories, Pharmacogenomics Services and Diagnostic Tools.
Why Should Investors Buy TBIO After the Recent Fall? Just Go Here and Find Out
In the last trading session, Universal Bioenergy Inc (OTCMKTS: UBRG) was down on high volume, trading at a volume of 78.75M versus its average daily volume of 7.53 million shares. At $0.0010, the stock has attained market capitalization of 852,950.00. Universal Bioenergy, Inc. (UB), formerly Palomine, Inc., is engaged in the production of renewable fuels. The Company is primarily focused on biodiesel fuel in the United States. Effective August 14, 2013, the board of Universal Bioenergy Inc completed the repurchase of about 12% of the Company's entire share capital in a privately negotiated transaction.
Why Should Investors Buy UBRG After the Recent Fall? Just Go Here and Find Out
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)